152 related articles for article (PubMed ID: 31779618)
1. Usefulness and reliability of cell free fetal DNA screening for main trisomies in case of atypical profile on first trimester maternal serum screening.
Carrara J; Vivanti A; Jani JC; Demain A; Costa JM; Benachi A
J Transl Med; 2019 Nov; 17(1):398. PubMed ID: 31779618
[TBL] [Abstract][Full Text] [Related]
2. Performance of cell-free DNA testing for common fetal trisomies in triplet pregnancies.
Zakaria H; Kleinfinger P; Lohmann L; Costa JM; Tsatsaris V; Salomon LJ; Jouannic JM; Rosenblatt J; Demain A; Benachi A; El Khattabi L; Vivanti AJ
Prenat Diagn; 2024 May; 44(5):555-561. PubMed ID: 38448008
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of early morphological ultrasound in association with cell-free DNA testing in case of atypical serum markers in first trimester of pregnancy: A retrospective study over 5 years.
Claudel N; Anselem O; Buron-Fouque C; Khattabi LE; Laguillier-Morizot C; Jordan P; Tsatsaris V; Guibourdenche J; Athiel Y
J Gynecol Obstet Hum Reprod; 2024 Apr; 53(4):102745. PubMed ID: 38367703
[TBL] [Abstract][Full Text] [Related]
4. Prenatal Genome-Wide Cell-Free DNA Screening: Three Years of Clinical Experience in a Hospital Prenatal Diagnostic Unit in Spain.
Pedrola Vidal L; Roselló Piera M; Martín-Grau C; Rubio Moll JS; Gómez Portero R; Marcos Puig B; Cervera Zamora JV; Quiroga R; Orellana Alonso C
Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790198
[TBL] [Abstract][Full Text] [Related]
5. Circulating Total Cell-Free DNA Levels Are Increased in Hypertensive Disorders of Pregnancy and Associated with Prohypertensive Factors and Adverse Clinical Outcomes.
Amaral LM; Sandrim VC; Kutcher ME; Spradley FT; Cavalli RC; Tanus-Santos JE; Palei AC
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33429954
[TBL] [Abstract][Full Text] [Related]
6. Detection of fetal trisomy and single gene disease by massively parallel sequencing of extracellular vesicle DNA in maternal plasma: a proof-of-concept validation.
Zhang W; Lu S; Pu D; Zhang H; Yang L; Zeng P; Su F; Chen Z; Guo M; Gu Y; Luo Y; Hu H; Lu Y; Chen F; Gao Y
BMC Med Genomics; 2019 Nov; 12(1):151. PubMed ID: 31684971
[TBL] [Abstract][Full Text] [Related]
7. Performance of a targeted cell-free DNA prenatal test for 22q11.2 deletion in a large clinical cohort.
Bevilacqua E; Jani JC; Chaoui R; Suk EA; Palma-Dias R; Ko TM; Warsof S; Stokowski R; Jones KJ; Grati FR; Schmid M
Ultrasound Obstet Gynecol; 2021 Oct; 58(4):597-602. PubMed ID: 34090308
[TBL] [Abstract][Full Text] [Related]
8. Application of mosaicism ratio to multifetal gestations.
Rafalko J; Caldwell S; Soster E; Almasri E; McLennan G; Liu T; Weinblatt V; Cacheris P; McCullough R
PLoS One; 2021; 16(3):e0248467. PubMed ID: 33711042
[TBL] [Abstract][Full Text] [Related]
9. Cell-Free Total and Fetal DNA in First Trimester Maternal Serum and Subsequent Development of Preeclampsia.
Silver RM; Myatt L; Hauth JC; Leveno KJ; Peaceman AM; Ramin SM; Samuels P; Saade G; Sorokin Y; Clifton RG; Reddy UM
Am J Perinatol; 2017 Jan; 34(2):191-198. PubMed ID: 27398706
[No Abstract] [Full Text] [Related]
10. Cost-effectiveness of ultrasound before non-invasive prenatal screening for fetal aneuploidy.
Battarbee AN; Vora NL; Hardisty EE; Stamilio DM
Ultrasound Obstet Gynecol; 2023 Mar; 61(3):325-332. PubMed ID: 36273429
[TBL] [Abstract][Full Text] [Related]
11. Early detection of active Human CytomegaloVirus (hCMV) infection in pregnant women using data generated for noninvasive fetal aneuploidy testing.
Faas BHW; Astuti G; Melchers WJG; Reuss A; Gilissen C; Macville MVE; Ghesquiere SAI; Houben LMH; Srebniak MI; Geeven G; Rahamat-Langendoen JC; Sistermans EA; Linthorst J
EBioMedicine; 2024 Feb; 100():104983. PubMed ID: 38365322
[TBL] [Abstract][Full Text] [Related]
12. Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants.
Soster E; Boomer T; Hicks S; Caldwell S; Dyr B; Chibuk J; Almasri E
Genet Med; 2021 Jul; 23(7):1349-1355. PubMed ID: 33731879
[TBL] [Abstract][Full Text] [Related]
13. Cell-free DNA test for fetal chromosomal abnormalities in multiple pregnancies.
Kwan AHW; Gil MM; Xue S; Kwok YKY; Lau D; Fung J; Chan A; Choy KW; Leung TY; Poon LC
Acta Obstet Gynecol Scand; 2024 Jun; ():. PubMed ID: 38924543
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive cell-free DNA-based approach for the diagnosis of clinical miscarriage: A retrospective study.
Balaguer N; Rodrigo L; Mateu-Brull E; Campos-Galindo I; Castellón JA; Al-Asmar N; Rubio C; Milán M
BJOG; 2024 Jan; 131(2):213-221. PubMed ID: 37533357
[TBL] [Abstract][Full Text] [Related]
15. Screen-positive rate in cell free DNA screening for trisomy 21.
Lüthgens K; Häbig K; Sonek J; Kagan KO
Prenat Diagn; 2023 Nov; 43(12):1536-1543. PubMed ID: 37789581
[TBL] [Abstract][Full Text] [Related]
16. Importance of a detailed anomaly scan after a cfDNA test indicating fetal trisomy 21, 18 or 13.
Spingler T; Sonek J; Hoopmann M; Prodan N; Jonaityte G; Elger T; Kagan KO
Arch Gynecol Obstet; 2023 Dec; ():. PubMed ID: 38091054
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive prenatal screening in a pregnant woman with a history of stem cell transplant from a male donor: A case report and literature review.
Liang D; Lin Y; Luo C; Li H; Hu P; Xu Z
Mol Genet Genomic Med; 2024 Jun; 12(6):e2479. PubMed ID: 38860502
[TBL] [Abstract][Full Text] [Related]
18. Prenatal cfDNA Screening for Emanuel Syndrome and Other Unbalanced Products of Conception in Carriers of the Recurrent Balanced Translocation t(11;22): One Laboratory's Retrospective Experience.
Soster E; Dyr B; Caldwell S; Sussman A; Magharyous H
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895273
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of cell-free DNA in maternal blood in detecting chromosomal anomalies in twin pregnancies: systematic review and meta-analysis.
Della Valle L; Piergianni M; Khalil A; Novelli A; Rizzo G; Mappa I; Prasad S; Matarrelli B; Gatta V; Stuppia L; Pagani G; Flacco ME; D'Antonio F
Ultrasound Obstet Gynecol; 2024 May; ():. PubMed ID: 38775911
[TBL] [Abstract][Full Text] [Related]
20. Eliminating first trimester combined testing: Consequences for early detection of significant fetal anomalies.
Lugthart MA; Heinrich H; Ertugrul I; Nsiah-Asare EN; van de Kamp K; Linskens IH; van Maarle MC; van Leeuwen E; Pajkrt E
Prenat Diagn; 2024 May; 44(5):544-554. PubMed ID: 38497783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
